Yesterday, associate Health minister Peter Dunne gave the green light for a patient with Tourette’s syndrome to use Aceso Calm Spray.
The spray is a cannabis based medication, which was chosen for the Wellington teenager because it has a comparatively low THC content.
Mr Dunne joined Paul Henry to talk about the decision and whether it would spread to a wider loosening of rules around medicinal cannabis.
"These are considered on a case-by-case basis. The driving point is always the patient's medical advisors and the application that they make. They are then assessed, and I then get a recommendation to act upon." Mr Dunne would like to see more clinical trials of cannabis based products, so that patients and doctors have more options for treatment."The situation for medicinal marijuana products is no different for any other new medicine. In other words, they have to be trialled and registered.”